Abstract
Objective
The aim of the study was to investigate the effect of Casticin (CAS) combination with Cisplatin (DDP) in sub-toxic concentration on apoptosis of human ovarian cancer HO-8910 cells in vitro and unravel the associated mechanisms.
Methods
Human ovarian cancer HO-8910 cells were cultured in vitro. The inhibitory effect of CAS combination with DDP in sub-toxic concentration on viability of human ovarian cancer HO-8910 cells was evaluated by the MTT assay. Morphological changes of cell apoptosis were detected by Hoechst 33258 staining assay. Cell apoptosis rate was analyzed by flow cytometry. The protein expression level was analyzed by Western blot.
Results
CAS in sub-toxic concentration and DDP in sub-toxic concentration could slightly inhibit Human ovarian cancer HO-8910 cells, but CAS combination with DDP in sub-toxic concentration significantly inhibited the growth of HO-8910 cells, and growth inhibition rate was increased drastically compared with the control group (P<0.01), and the inhibiting effect showed synergistic action. Human ovarian cancer HO-8910 cells showed the typical morphological changes of apoptosis and apoptosis rate markedly increased when they were exposed to CAS combination with DDP in sub-toxic concentration for 48 h. Western blot showed that the expression of bcl-2 protein was down-regulated and protein level of caspase-3 was activated by CAS combination with DDP in sub-toxic concentration.
Conclusion
CAS combination with DDP in sub-toxic concentration could inhibit the cells growth and lead to cell apoptosis in human ovarian cancer HO-8910 cells. And the down-regulation of bcl-2 protein expression and activation of caspase-3 protein might contribute to CAS combination with DDP in sub-toxic concentration in human cancer HO-8910 cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Su W, Huang L, Ao Q, et al. Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α. Cancer Lett, 2011, 305: 94–99.
Xie J, Bai J, Sheng XF, et al. Proliferation inhibition of human cervical cancer HeLa cell by Casticin in vitro. Chinese-German J Clin Oncol, 2011, 10: 47–50.
Zeng F, Tian L, Liu F, et al. Induction of apoptosis by casticin in cervical cancer cells: reactive oxygen species-dependent sustained activation of Jun N-terminal kinase. Acta Biochim Biophys Sin (Shanghai), 2012, 44: 442–449.
Yang J, Yang Y, Tian L, et al. Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells. World J Gastroenterol, 2011, 17: 4298–4307.
Kobayakawa J, Sato-Nishimori F, Moriyasu M, et al. G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil). Cancer Lett, 2004, 208: 59–64.
Haïdara K, Zamir L, Shi QW, et al. The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett, 2006, 242: 180–190.
Shen JK, Du HP, Yang M, et al. Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol, 2009, 88: 743–752.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a grant from the Hunan Provincial Education Department (No. 2011.91.11C1109).
Rights and permissions
About this article
Cite this article
Bai, J., Tan, G., Chen, L. et al. Casticin combination with Cisplatin in sub-toxic concentration induced apoptosis of human ovarian cancer HO-8910 cells in vitro. Chin. -Ger. J. Clin. Oncol. 12, 35–39 (2013). https://doi.org/10.1007/s10330-012-1096-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-012-1096-4